Home
About Us
Company Profile
Development History
Corporate Vision
Our Team
Company Honors
Market
Aerospace & Defense
Medical
Tech Industrial
Solution
Manufacturing
Engineering Solutions
New Product Introduction
After Market Services
Blog
Company News
Industry Trends
Careers
Contact
CN
27
2026-01
Bid farewell to supply chain passivity—Creation's rapid response empowers OEMs to expand profitability.
For OEM partners, supply chain responsiveness is non-negotiable—especially in high-mix, low-volume (HMLV) environments where market dynamics shift in the blink of an eye.
2026-01-27
26
De-verticalization: Win More by Focusing on Your Core, Not Controlling Every Process
In an era of rapid technological iteration and increasingly segmented industrial chains, many enterprises are still trapped in the myth of "controlling every production process". However, de-verticalization — focusing on core competencies and outsourcing non-core links to professional partners — has become a strategic choice for high-growth enterprises to reduce costs, improve efficiency and enhance competitiveness.
2026-01-26
07
When Surgical Robots Gain “Tactile Sensation”: Creation Technologies High-Precision PCBA Empowers the Future of Precision Medicine
In millimeter-level dissection during neurosurgery and in the delicate manipulation of cardiovascular interventions, surgeons have long faced a daunting challenge: While traditional surgical robots extend the operating radius, they fail to convey the authentic tactile feedback between instruments and human tissue. It's like threading a needle in fog—relying solely on visual judgment to gauge force—which inadvertently increases the risk of tissue damage and intraoperative bleeding.
2026-01-07
31
2025-12
2025 Review & 2026 Outlook
In 2025, amid ongoing changes in the global manufacturing landscape, Creation Technologies Changzhou continued to pursue stable operations and high-quality growth. Guided by customer needs and core capability development, the site further strengthened its competitiveness in high-mix, low-to-medium volume manufacturing.
2025-12-31
ISO13485 vs. GMP: Critical for Medical Device MAH Contract Manufacturing
Per China’s Medical Devices Registration Administration Method, the Marketing Authorization Holder (MAH) system separates medical device registrants from manufacturers, boosting industry flexibility while raising demands on registrants’ responsibilities and management capabilities. For Medical OEM clients seeking Chinese MAH contract manufacturing partners, supply chain compliance is pivotal—and ISO13485 and GMP are the two core certification focus areas.
16
4 Core Challenges Global Med/Industrial OEMs Face When Localizing PCBA in China (And How to Solve Them)
The strategic shift to localize Printed Circuit Board Assembly (PCBA) manufacturing in China offers undeniable benefits in cost efficiency and supply chain agility. Yet, for Global Medical and Industrial OEMs, this move is often fraught with subtle, high-stakes risks that compromise product integrity and speed-to-market. As more than 20years experiences in EMS field at China, I've seen firsthand where these localization efforts typically break down. It’s rarely about unit price; it’s about the hidden cost of non-compliance, poor quality culture, and security risks. Success lies in recognizing these challenges before they become critical failures.
2025-12-16